21 May 2013
Keywords: roche, sells, 16b, bonds, finance, renewed, genentech
Article | 23 February 2009
Roche has sold bonds worth $16.0 billion to finance its takeover of US biotechnology firm Genentech. The Swiss drug major is ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
23 February 2009
20 May 2013
© 2013 thepharmaletter.com